Adjuvant mecobalamin for anti-VEGF therapy in retinal vein occlusion: protocol of a single-centre, randomised, double-blinded controlled trial. [PDF]
BMJ OpenLiu KY +8 more
europepmc +1 more source
Adjuvant Anti-VEGF in Vitrectomy for Proliferative Diabetic Retinopathy: Current Evidence, Timing Considerations, and Clinical Implications. [PDF]
Curr Ophthalmol RepCoelho-Costa I, Falcão M, Goldhardt R.
europepmc +1 more source
Preoperative intravitreal injection of conbercept improves the efficacy of neovascular glaucoma surgery. [PDF]
Am J Transl ResChen L, Zhou J, Lou Q, Chen T, Cheng Y.
europepmc +1 more source
Evaluation of Ahmed glaucoma valve versus Ex-PRESS shunt implantation with conbercept therapy in neovascular glaucoma. [PDF]
Medicine (Baltimore)Zhou L, Liu Y.
europepmc +1 more source
Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema. [PDF]
BMC OphthalmolShi XN +4 more
europepmc +1 more source
Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]
Front Med (Lausanne)Ji M, Wei W, Gong H, Zhang G.
europepmc +1 more source
Effect of Adjuvant Conbercept on Patients with Macular Edema Induced by Diabetic Retinopathy and Retinal Vein Occlusion Undergoing Laser Treatment: Impact on Symptom Improvement. [PDF]
Int J Gen MedCai L, Wang J, Huang D, Cai Z.
europepmc +1 more source
Efficacy and safety of different anti-VEGF agents combined with pars plana vitrectomy in proliferative diabetic retinopathy: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Front Endocrinol (Lausanne)Lu S, Lin Y, Lin L, Chen S.
europepmc +1 more source
Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization. [PDF]
Int J OphthalmolLiu JY, Liu JP, Li XR.
europepmc +1 more source